Scott B. Ullem - 21 Feb 2023 Form 4 Insider Report for Edwards Lifesciences Corp (EW)

Role: CVP, Chief Financial Officer
Signature: Linda J. Park, Attorney-in-Fact
Issuer symbol: EW
Transactions as of: 21 Feb 2023
Transactions value $: $-26,301
Form type: 4
Filing time: 21 Feb 2023, 19:57:33 UTC
Previous filing: 17 Feb 2023
Next filing: 04 May 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	EW	Common Stock	Tax liability	$-26,301	-335	-1.85%	$78.51	17,784	21 Feb 2023	Direct
holding	EW	Common Stock						257,822	21 Feb 2023	By Trust

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.